News Search Results
Oct 26, 2026, 04:00 ET Coway Airmega Mighty2 Named to TIME's Best Inventions of 2026
real-time numerical air quality readings and a 4-color LED indicator.20% Lower Energy Use & 19dB Quiet Operation: Consumes just 56W and operates as quietly as 19 decibels for maximum energy efficiency and peaceful sleep environments.Award-Winning Design: Blends seamlessly
More news about: Coway
Oct 26, 2026, 03:55 ET Share buybacks in Ericsson during the period October 19 - October 23, 2026
2026 /PRNewswire/ -- During the period October 19 - October 23, 2026, Telefonaktiebolaget LM Ericsson (publ) ("Ericsson") (LEI code 549300W9JLPW15XIFM52) repurchased own Class B shares (ISIN: SE0000108656) as follows:
More news about: Ericsson
Oct 26, 2026, 03:27 ET Minesto and Morteza Capital join forces to commercialize tidal energy in the Maldives
Taiwan. Major shareholder is Corespring New Technology. The Minesto share (MINEST) is traded on Nasdaq First North Growth Market. Certified Adviser is G&W Fondkommission.Read more about Minesto at
More news about: Minesto AB
Oct 25, 2026, 21:31 ET Heybike Launches V1 Pro, a 72V Power Beast with 8,000W Peak Power and Bigger Attitude
Pro, a 72V electric dirt bike designed for riders who want bigger tires, bigger attitude, and ultimate off-road performance. With 8,000W peak power, 17-inch front and 14-inch rear tires, and Wheelie Boost Assist, the V1 Pro delivers powerful off-road performance while
More news about: Heybike
Oct 25, 2026, 20:00 ET Antengene Presents Latest Clinical Results for ATG-022 and ATG-037 at ESMO 2026
patients with advanced solid tumors were enrolled regardless of CLDN18.2 expression and received ATG-022 once every three weeks at doses of 0.3–3.0 mg/kg (Q3W). In the Phase Ⅱ dose expansion, CLDN18.2-positive (IHC 1+, ≥1%) patients were enrolled to receive ATG-022 monotherapy at 1.8 mg/kg or 2.4 mg/kg. The
More news about: Antengene Corporation Limited
Oct 25, 2026, 17:00 ET INVESTOR DEADLINE: D-Wave Quantum Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 15, 2026 Deadline - GIL
offices. Contact: Robbins Geller Rudman & Dowd LLP Ken Dolitsky Michael Albert 655 W. Broadway, Suite 1900, San Diego, CA 92101 800/851-7783 [email protected]
More news about: Robbins Geller Rudman & Dowd LLP
Oct 25, 2026, 11:24 ET INVESTOR DEADLINE: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline
offices. Contact: Robbins Geller Rudman & Dowd LLP Ken Dolitsky Michael Albert 655 W. Broadway, Suite 1900, San Diego, CA 92101 800/851-7783 [email protected]
More news about: Robbins Geller Rudman & Dowd LLP
Oct 25, 2026, 10:45 ET INVESTOR DEADLINE: Gildan Activewear Inc. Investors with Substantial Losses May Seek to Lead the Gildan Activewear Class Action Lawsuit Before December 14, 2026 Deadline - GIL
offices. Contact: Robbins Geller Rudman & Dowd LLP Ken Dolitsky Michael Albert 655 W. Broadway, Suite 1900, San Diego, CA 92101 800/851-7783 [email protected]
More news about: Robbins Geller Rudman & Dowd LLP
Oct 25, 2026, 07:01 ET Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO
randomized, multicenter, open-label Phase III study. A total of 376 patients were enrolled and randomized (1:1) to receive sac-TMT monotherapy (5 mg/kg Q2W) or platinum-based doublet chemotherapy (pemetrexed plus platinum). The primary endpoint was BICR-assessed PFS, and OS was a key secondary endpoint.
More news about: Kelun-Biotech
Oct 25, 2026, 04:09 ET TCL Zhonghuan, REI Expo 2026'da Güneş Enerjisi Yenilikleriyle Hindistan'ın Enerji Dönüşümüne Öncülük Ediyor
tasarıma sahipken, X5 modeli ise uzak bölgeler ve sanayi parkları için fotovoltaik sistemler ve dizel jeneratörlerle uyumlu çalışmayı desteklemektedir. W10 ticari ve endüstriyel enerji yönetimi ihtiyaçlarını karşılamak üzere sıvı soğutma ve yapay zeka destekli erken uyarı özelliklerini benimsemiştir. Bu
More news about: TCL Zhonghuan
Oct 25, 2026, 02:00 ET 2026 ESMO | Innovent Announcement Phase 2 Data Presentation for IBI354 (HER2 ADC) In First-line Treatment of Breast Cancer
HER2-positive, unresectable locally advanced, or metastatic breast cancer. As of July 1, a total of 20 patients were enrolled to receive IBI354 9mg/kg Q3W in combination with pertuzumab, with a median follow-up of 9.6 months (range: 9–11) and a median treatment duration of 42.21 weeks (range: 24.1–49.0).IBI354
More news about: Innovent Biologics, Inc.
Oct 23, 2026, 17:42 ET Wisconsin Brats vs. Florida Citrus: Johnsonville and Florida's Natural Put Hometown Flavor on the Line with Big League Bet
and Florida's Natural are raising the stakes in the race to win it all, giving their opponent's city something extra to celebrate if they take home the W.
More news about: Johnsonville
Oct 23, 2026, 15:59 ET TCL Zhonghuan accélère la transition énergétique de l'Inde grâce à ses innovations photovoltaïques présentées à l'exposition REI 2026
en charge le fonctionnement coordonné avec les systèmes photovoltaïques et les générateurs diesel pour les zones reculées et les parcs industriels. Le W10 adopte un système de refroidissement liquide et des capacités d'alerte précoce basées sur l'IA pour répondre aux besoins de gestion de l'énergie des
More news about: TCL Zhonghuan
Oct 23, 2026, 13:08 ET TCL Zhonghuan impulsa la transición energética de la India con innovaciones fotovoltaicas en REI Expo 2026
mientras que el X5 permite el funcionamiento coordinado con sistemas fotovoltaicos y generadores diésel para zonas remotas y parques industriales. El modelo W10 incorpora refrigeración líquida y funciones de alerta temprana basadas en inteligencia artificial para satisfacer las necesidades de gestión energética
More news about: TCL Zhonghuan
Oct 23, 2026, 11:59 ET 1 WEEK YSS INVESTOR DEADLINE: York Space Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before October 30, 2026 Deadline
offices. Contact: Robbins Geller Rudman & Dowd LLP Ken Dolitsky Michael Albert 655 W. Broadway, Suite 1900, San Diego, CA 92101 800/851-7783 [email protected]
More news about: Robbins Geller Rudman & Dowd LLP
Oct 23, 2026, 10:21 ET TCL Zhonghuan treibt Indiens Energiewende mit PV-Innovationen auf der REI Expo 2026 voran
Unternehmen aus, während der X5 den koordinierten Betrieb mit PV-Systemen und Dieselgeneratoren für abgelegene Gebiete und Industrieparks unterstützt. Der W10 nutzt Flüssigkeitskühlung und KI-gestützte Frühwarnfunktionen, um den Energiemanagementanforderungen von Gewerbe und Industrie gerecht zu werden. Zusammen
More news about: TCL Zhonghuan
Oct 23, 2026, 10:01 ET TCL Zhonghuan Powers India's Energy Transition with PV Innovations at REI Expo 2026
homes and small businesses, while the X5 supports coordinated operation with PV systems and diesel generators for remote areas and industrial parks. The W10 adopts liquid cooling and AI-powered early-warning capabilities to meet C&I energy management needs. Together, the series offers flexible storage
More news about: TCL Zhonghuan
Oct 23, 2026, 09:23 ET Notice of Pendency and Proposed Settlement Involving All Record and Beneficial Holders of dMY Technology Group, Inc. IV ("dMY IV") Class A Common Stock Between December 1, 2021 and December 7, 2021
[email protected] W. LuedekeRobbins Geller Rudman & Dowd LLP655 W. Broadway, Suite 1900San Diego, CA 92101Telephone: (619) 231-1058Email:
More news about: JND Legal Administration
Oct 23, 2026, 08:54 ET SINEXCEL uzyskuje certyfikat IEC 62443-4-1 potwierdzający zgodność z wymogami cyberbezpieczeństwa
sterowania, wspierając producentów w tworzeniu skutecznych praktyk z zakresu cyberbezpieczeństwa na wszystkich etapach cyklu życia produktu. Zawarte w niej zasady stanowią również podstawę do spełniania zmieniających się wymogów regulacyjnych i oczekiwań klientów, w tym wymogów unijnego Aktu o cyberodporności
More news about: SINEXCEL
Oct 23, 2026, 08:30 ET At ESMO 2026, Sun Pharma to Present Long-Term Follow-up Data on UNLOXCYT® (cosibelimab-ipdl) from One of the Largest Prospective Studies in Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
CSCC cohorts using centrally-reviewed data. In Group 1, mCSCC patients received 800 mg Q2W, Group 2 included laCSCC patients who also received 800 mg Q2W, and the Group 3 mCSCC cohort of patients received 1,200 mg Q3W. The primary endpoint was objective response rate (ORR) by central review. Secondary endpoints
More news about: Sun Pharma
Oct 23, 2026, 08:24 ET GMIF2026 Exhibition Recap: Innovation Across the AI Memory & Storage Chain on Show
manufacturing covering wafer grinding and polishing, femtosecond laser surface dicing, plasma dicing, and hybrid bonding (D2W/W2W). Its integrated grinding-polishing and laser dicing equipment has been adopted across leading domestic OSATs, covering 8-inch and 12-inch memory
More news about: Shenzhen Memory Industry Association
Oct 23, 2026, 06:55 ET Bezpieczeństwo. Dla rodziny | Wyniki testu zderzeniowego TIGGO7 potwierdzają dbałość firmy CHERY o bezpieczeństwo rodzin
automatycznie w chwili zderzenia, inicjując wezwanie pomocy; słupki A i B oraz drzwi pozostały nienaruszone, bez istotnego naruszenia przestrzeni przedziału pasażerskiego; napinacze pasów bezpieczeństwa i poduszki powietrzne zadziałały w sposób skoordynowany, chroniąc manekiny użyte w teście zderzeniowym.Historie
More news about: Chery Automobile Co., Ltd.
Oct 23, 2026, 06:00 ET IDE849 (SHR-4849) DLL3 TOP1 ADC Updated Phase 1 Results at ESMO 2026 Demonstrates Promising Anti-Tumor Activity and Preliminary Overall Survival Results in Relapsed Small Cell Lung Cancer and Neuroendocrine Carcinomas
2026 data cutoff, 122 patients had enrolled, including 103 with SCLC and 19 with other NECs at IDE849 doses ≥1.8 mg/kg IV dosed once every 3-weeks (Q3W). Median follow-up was 12.1 months (interquartile range: 8.2–16.0 months). Among patients with SCLC, 78.6% (81/103) had received prior immunotherapy,
More news about: IDEAYA Biosciences, Inc.
Oct 22, 2026, 22:36 ET MAXHUB Brings Full-Scenario Collaboration Solutions to InfoComm América Latina 2026
MAXHUB is showcasing its smart meeting solutions, including the XBar W70 Kit and XBoard V7 series, designed to connect meeting room displays, audio pickup and room scheduling into a more integrated experience.The XBar W70 Kit, the industry's first Windows-based Teams Rooms videobar,
More news about: MAXHUB
Oct 22, 2026, 19:30 ET QBTS INVESTOR DEADLINE: D-Wave Quantum Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - December 15, 2026 Deadline
any of our offices. Contact:Robbins Geller Rudman & Dowd LLPKen DolitskyMichael Albert655 W. Broadway, Suite 1900, San Diego, CA 92101800/[email protected]
More news about: Robbins Geller Rudman & Dowd LLP